In addition, studies in rodents with FGF21 reveal several potential areas of side-effect concerns that need monitoring, such as potential interactions with the growth hormone axis (103, 104), decreases in bone mineral density (105), increases in plasma corticosterone levels (106), cross-talk with the PPARγ axis (107), and female infertility (108). This evidence concerns the gene PPARG and female infertility.